- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 317/46 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Patent holdings for IPC class C07D 317/46
Total number of patents in this class: 172
10-year publication summary
|
17
|
22
|
15
|
19
|
10
|
15
|
12
|
11
|
13
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Autifony Therapeutics Limited | 47 |
11 |
| Arbutus Biopharma Corporation | 189 |
8 |
| BASF SE | 20367 |
7 |
| Vertex Pharmaceuticals Incorporated | 1570 |
7 |
| CHDI Foundation, Inc. | 108 |
5 |
| Shenyang Sinochem Agrochemicals R&D Co., Ltd. | 104 |
5 |
| H. Lundbeck A/S | 1247 |
5 |
| Biosplice Therapeutics, Inc. | 162 |
5 |
| Bristol-myers Squibb Company | 4886 |
4 |
| Jiangsu Yangnong Chemical Co., Ltd. | 58 |
4 |
| The Scripps Research Institute | 1353 |
4 |
| Janssen Pharmaceutica N.V. | 3625 |
3 |
| JSR Corporation | 2473 |
3 |
| SRF Limited | 51 |
3 |
| F. Hoffmann-La Roche AG | 7942 |
2 |
| LG Chem, Ltd. | 17620 |
2 |
| Allergan, Inc. | 2445 |
2 |
| Abbvie Inc. | 1781 |
2 |
| Brock University | 63 |
2 |
| Firmenich SA | 1667 |
2 |
| Other owners | 86 |